PharmatrophiX
Raleigh
About PharmatrophiX
San Francisco's PharmatrophiX, a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.8M
- Last round: Debt Financing (Nov 2015)
- Website: pharmatrophix.comindex.html
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharmatrophix-2226999 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.